Steve Slilaty

Track

Insider profile

Currently holds a position at Sunshine Biopharma Inc

Positions

Position Company Period
Chairman of the Board, President, Chief Executive Officer Sunshine Biopharma Inc Oct. 15, 2009 -
Steve Slilaty's trades of Sunshine Biopharma Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Purchase
Price
41.17
Quantity 67,457 +43.6%
Value US$1,960,668
Transaction date
Purchase
Price
181.84
Quantity 36,679 +12.3%
Value US$2,003,530
Transaction date
Purchase
Price
489.44
Quantity 21,274 -49.1%
Value US$580,254
Transaction date
Purchase
Price
0.10
Quantity 500,000 +inf%
Value US$50,000
Transaction date
Sale
Price
0.05
Quantity 2,591,500 -7.6%
Value US$129,575
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-03-05 2024-03-04
B Purchase
67,457 +43.6%
41.17
US$1,960,668 		67,457 +43.6% 41.17 US$1,960,668
2024-02-12 2024-02-08
B Purchase
36,679 +12.3%
181.84
US$2,003,530 		36,679 +12.3% 181.84 US$2,003,530
2016-04-26 2016-04-12
B Purchase
21,274 -49.1%
489.44
US$580,254 		21,274 -49.1% 489.44 US$580,254
2015-06-01 2015-05-27
B Purchase
500,000 +inf%
0.10
US$50,000 		500,000 +inf% 0.10 US$50,000
2012-09-07 2012-09-04
S Sale
2,591,500 -7.6%
0.05
US$129,575 		2,591,500 -7.6% 0.05 US$129,575